These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 16972761)
1. Deletion of VAI and VAII RNA genes in the design of oncolytic adenoviruses. Cascallo M; Gros A; Bayo N; Serrano T; Capella G; Alemany R Hum Gene Ther; 2006 Sep; 17(9):929-40. PubMed ID: 16972761 [TBL] [Abstract][Full Text] [Related]
2. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy. Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895 [TBL] [Abstract][Full Text] [Related]
3. Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors. Wang Y; Xue SA; Hallden G; Francis J; Yuan M; Griffin BE; Lemoine NR Cancer Res; 2005 Feb; 65(4):1523-31. PubMed ID: 15735041 [TBL] [Abstract][Full Text] [Related]
4. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus. Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462 [TBL] [Abstract][Full Text] [Related]
5. Establishment of a mouse melanoma model system for the efficient infection and replication of human adenovirus type 5-based oncolytic virus. Kang S; Kim JH; Kim SY; Kang D; Je S; Song JJ Biochem Biophys Res Commun; 2014 Oct; 453(3):480-5. PubMed ID: 25280999 [TBL] [Abstract][Full Text] [Related]
6. Heat shock phenocopies E1B-55K late functions and selectively sensitizes refractory tumor cells to ONYX-015 oncolytic viral therapy. O'Shea CC; Soria C; Bagus B; McCormick F Cancer Cell; 2005 Jul; 8(1):61-74. PubMed ID: 16023599 [TBL] [Abstract][Full Text] [Related]
7. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model. Wang H; Wei F; Li H; Ji X; Li S; Chen X Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955 [TBL] [Abstract][Full Text] [Related]
8. E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects. Kim J; Kim JH; Choi KJ; Kim PH; Yun CO Hum Gene Ther; 2007 Sep; 18(9):773-86. PubMed ID: 17725410 [TBL] [Abstract][Full Text] [Related]
9. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo. Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy. Kim J; Cho JY; Kim JH; Jung KC; Yun CO Cancer Gene Ther; 2002 Sep; 9(9):725-36. PubMed ID: 12189522 [TBL] [Abstract][Full Text] [Related]
11. Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells. Zheng X; Rao XM; Snodgrass CL; McMasters KM; Zhou HS Cancer Gene Ther; 2006 Jun; 13(6):572-83. PubMed ID: 16341141 [TBL] [Abstract][Full Text] [Related]
12. Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin. Yoon AR; Kim JH; Lee YS; Kim H; Yoo JY; Sohn JH; Park BW; Yun CO Hum Gene Ther; 2006 Apr; 17(4):379-90. PubMed ID: 16610926 [TBL] [Abstract][Full Text] [Related]
13. Impact of E1a modifications on tumor-selective adenoviral replication and toxicity. Sauthoff H; Pipiya T; Heitner S; Chen S; Bleck B; Reibman J; Chang W; Norman RG; Rom WN; Hay JG Mol Ther; 2004 Oct; 10(4):749-57. PubMed ID: 15451459 [TBL] [Abstract][Full Text] [Related]
14. Ras-dependent oncolysis with an adenovirus VAI mutant. Cascalló M; Capellà G; Mazo A; Alemany R Cancer Res; 2003 Sep; 63(17):5544-50. PubMed ID: 14500393 [TBL] [Abstract][Full Text] [Related]
15. High level of transgene expression in cell cultures and in the mouse by replication-incompetent adenoviruses harboring modified VAI genes. Eloit M; Adam M; Gallais I; Fournier A J Virol; 1997 Jul; 71(7):5375-81. PubMed ID: 9188608 [TBL] [Abstract][Full Text] [Related]
16. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin. Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637 [TBL] [Abstract][Full Text] [Related]
17. Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein. Shen Y; Kitzes G; Nye JA; Fattaey A; Hermiston T J Virol; 2001 May; 75(9):4297-307. PubMed ID: 11287579 [TBL] [Abstract][Full Text] [Related]
18. Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: the importance of the adenoviral E1b-55kD gene. Hay JG; Shapiro N; Sauthoff H; Heitner S; Phupakdi W; Rom WN Hum Gene Ther; 1999 Mar; 10(4):579-90. PubMed ID: 10094201 [TBL] [Abstract][Full Text] [Related]
19. E4orf1 limits the oncolytic potential of the E1B-55K deletion mutant adenovirus. Thomas MA; Broughton RS; Goodrum FD; Ornelles DA J Virol; 2009 Mar; 83(6):2406-16. PubMed ID: 19129452 [TBL] [Abstract][Full Text] [Related]